Jochen Willner
Papers
1
Total Citations
11
H-Index
1
About
Jochen Willner is a leading figure in the field of radiation oncology, with a focused expertise in stereotactic body radiotherapy (SBRT) for pulmonary tumors. His most impactful work addresses a critical challenge in the discipline: the lack of standardization in dose prescription and delivery across different institutions and technologies. In his highly cited 2021 study, Willner proposed a novel solution by advocating for dose prescription to the mean internal target volume (ITV) dose. This approach, which has garnered 11 citations, aims to improve interinstitutional and intertechnology consistency, directly tackling the problematic variations in dose profiles and normalization that can compromise treatment efficacy and comparability. By establishing a more uniform dosimetric framework, his research provides a practical pathway for harmonizing clinical practices, making SBRT outcomes more reproducible and reliable. Willner’s contributions are instrumental for clinicians and physicists seeking to refine treatment protocols, ensuring that advances in SBRT technology translate into consistent, high-quality patient care across the global oncology community.
Research Focus
Key Achievements
Top Papers
- 1